Hefei Lifeon Pharmaceutical Co., Ltd.(XSEC:003020) added to S&P Global BMI Index
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.66 CNY | -3.72% | -4.14% | -16.19% |
05-21 | Lifeon Pharmaceutical's Unit Gets Marketing Authorization for Loxoprofen Sodium Oral Solution | MT |
05-15 | Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.19% | 520M | |
+43.64% | 754B | |
+39.87% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+12.05% | 217B | |
-1.15% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- 003020 Stock
- News Hefei Lifeon Pharmaceutical Co., Ltd.
- Hefei Lifeon Pharmaceutical Co., Ltd.(XSEC: 003020) added to S&P Global BMI Index